Author | Johanna Bendell, MD | OncLive

Author | Johanna Bendell, MD


Dr. Bendell on using OMP-59R5 to treat Pancreatic Cancer

February 21, 2014

Johanna Bendell, MD, director of GI Cancer Research Program, associate director, Drug Development Program, Sarah Cannon Research Institute, discusses the anti-cancer stem cell antibody OMP-59R5 as a treatment option for patients with metastatic pancreatic cancer.